Dr. Rebecca J. McCrery, MD

Dr. McCrery practices at Pacific Surgery Center East in Omaha, Nebraska.

Dr. McCrery's NPI, 1316978695, was assigned on July 5, 2006. Dr. McCrery graduated from University of Minnesota Medical School in 1999. Dr. McCrery holds Nebraska license 23724.

Dr. McCrery's primary practice is Pacific Surgery Center East, at 111 S 90th St, Omaha, NE 68114 in Douglas County. The practice phone is (402) 397-7178.

Dr. McCrery's primary practice is Pacific Surgery Center East in Omaha, Nebraska. Dr. McCrery is also affiliated with Methodist Hospital. The medical group on file is UroHealth Partners. Dmand AI also links Dr. McCrery to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCrery practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. McCrery's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. McCrery is licensed in Nebraska.

CMS data shows 10,280 Medicare services from Dr. McCrery across 49 procedure codes in 2024, for 731 Medicare patients. Medicare paid $425,831 for them.

CMS counts 731 Medicare patients who saw Dr. McCrery in 2024. The largest group is 65 to 74, with 381 patients. 70% of them have high cholesterol, and 66% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McCrery's median patient age at 69, with 99% women.

In 2024, Dr. McCrery wrote 2,161 Medicare Part D claims for 582 patients. 64% of them were for generic drugs. CMS names the drug for 2,061 of them, across 30 drugs with 11 or more claims each, at $539,884 in total drug cost. In 2023, CMS named 1,455 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. McCrery for performance year 2024, reported as part of a group. Dr. McCrery accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McCrery as offering telehealth. CMS counts 46 procedures of removal of the uterus by Dr. McCrery, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. McCrery, published from 2019 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Urinary Incontinence, Urge, Electric Stimulation Therapy and Implantable Neurostimulators. Dr. McCrery has published most often in Neurourol Urodyn. Dr. McCrery's most frequent co-authors are Kevin D. Benson, MD, Felicia L. Lane, MD and Osvaldo Francisco Padron, MD.

Dmand AI links Dr. McCrery to 5 clinical trials. Conditions studied include Urinary Incontinence, Urge, Rectocele and Urinary Incontinence, Stress. Coloplast A/S sponsors the most, 2.

CMS Open Payments shows 630 general payments to Dr. McCrery from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Astellas Pharma US Inc paid the most, $40,969. It also lists 69 research payments totaling $172,871 from 2016 to 2021.

Dr. McCrery graduated from University of Minnesota Medical School in 1999.